Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (18)

Company Market Cap Price
ABT Abbott Laboratories
Home health monitoring devices align with Abbott's remote patient monitoring capabilities and consumer health monitoring offerings.
$215.16B
$123.64
-0.83%
CAH Cardinal Health, Inc.
At-home health monitoring devices as part of the at-home solutions business.
$45.55B
$190.72
+0.46%
RMD ResMed Inc.
Home health monitoring devices feature in ResMed's ecosystem.
$36.15B
$246.78
-2.17%
IRTC iRhythm Technologies, Inc.
Home health monitoring devices used for remote patient monitoring.
$6.02B
$187.62
+1.90%
SENS Senseonics Holdings, Inc.
CGM device is used in home health monitoring environments, aligning with Home Health Monitoring Devices as a direct product category.
$4.61B
$7.09
-1.66%
AHCO AdaptHealth Corp.
Offers at-home health monitoring devices and systems for remote patient monitoring.
$1.21B
$8.98
+0.39%
INGN Inogen, Inc.
Home health monitoring devices relevance: Inogen's home-use oxygen concentrators and related devices.
$221.55M
$8.23
+0.80%
HBB Hamilton Beach Brands Holding Company
Home health monitoring devices tied to HealthBeacon’s at-home patient monitoring platform and subscription model.
$192.64M
$13.94
-0.64%
OWLT Owlet, Inc.
Devices are designed for at-home infant health monitoring, i.e., Home Health Monitoring Devices.
$153.68M
$9.27
-2.16%
QIPT Quipt Home Medical Corp.
Quipt offers home health monitoring devices as part of its remote patient monitoring and in-home care offerings.
$105.57M
$2.44
+4.96%
BEAT HeartBeam, Inc.
At-home health monitoring device suitable for Home Health Monitoring Devices.
$62.54M
$1.84
+14.29%
ZJYL Jin Medical International Ltd.
Product portfolio includes home health monitoring devices as part of at-home care solutions.
$36.48M
$0.23
-22.06%
DRIO DarioHealth Corp.
Home Health Monitoring Devices are part of the at-home care ecosystem integrated with the platform.
$30.74M
$14.01
+2.56%
NXL Nexalin Technology, Inc.
Home health monitoring devices category applied to at-home brain stimulation with physician oversight.
$25.77M
$1.53
KNW Know Labs, Inc.
Home health monitoring devices category relevant to CGM wearables used by individuals at home.
$16.05M
$2.14
ALUR Allurion Technologies Inc.
Connected scale and home health monitoring capabilities via VCS/Allurion ecosystem.
$13.80M
$1.83
APYP AppYea, Inc.
Home health monitoring devices category applies to at-home sleep monitoring wearables.
$9.09M
$0.02
BTCY Biotricity, Inc.
Home Health Monitoring Devices targeted at patient self-management and remote monitoring.
$5.28M
$0.57

Loading company comparison...

Loading research report...

BEAT HeartBeam, Inc.

HeartBeam and HeartNexus Partner to Launch 24/7 Cardiology Reader Service

Oct 28, 2025
OWLT Owlet, Inc.

Owlet Announces Pricing of Public Offering of Class A Common Stock

Oct 22, 2025
OWLT Owlet, Inc.

Owlet Secures CDSCO Approval for Dream Sock, Targets 2026 Launch in India

Oct 15, 2025
DRIO DarioHealth Corp.

DarioHealth Secures Six New Employer Clients, Expanding Value‑Based Care Portfolio

Oct 13, 2025
DRIO DarioHealth Corp.

DarioHealth Partners with OneStep to Integrate Smartphone-Based Fall Risk Assessment into Multi‑Condition Platform

Oct 06, 2025
QIPT Quipt Home Medical Corp.

Nuveen LLC Acquires New Stake in Quipt Home Medical Corp.

Sep 21, 2025
QIPT Quipt Home Medical Corp.

Forager Capital Management Criticizes Quipt Board's Inaction on Acquisition Offer

Sep 10, 2025
BTCY Biotricity, Inc.

Biotricity Collaborates with Health-E Commerce to Expand Bioheart® Access to 70 Million FSA/HSA Users

Sep 09, 2025
BTCY Biotricity, Inc.

Biotricity and B-Secur Expand Partnership to Target Consumer Wearables Market

Sep 03, 2025
QIPT Quipt Home Medical Corp.

Forager Capital Management Challenges Quipt Board's Rejection, Reiterates $3.10 Offer

Sep 03, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Board Rejects Forager's $3.10 Per Share Acquisition Offer, Citing Undervaluation and Self-Serving Tactics

Aug 27, 2025
QIPT Quipt Home Medical Corp.

Forager Capital Management Submits Fully Financed Proposal to Acquire Quipt Home Medical for $3.10 Per Share

Aug 25, 2025
BTCY Biotricity, Inc.

Biotricity Reports Strong Q1 Fiscal Year 2026 Results with Positive EBITDA and Revenue Growth

Aug 14, 2025
BTCY Biotricity, Inc.

Biotricity Pre-Announces Positive EBITDA for Q1 Fiscal Year 2026

Aug 12, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Forms Strategic Joint Venture with Major Health Systems to Acquire Hart Medical Equipment

Aug 12, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results with Positive Organic Growth

Aug 11, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Schedules Fiscal Third Quarter 2025 Financial Results Release

Jul 29, 2025
BTCY Biotricity, Inc.

Biotricity Reports Strong Fiscal Year 2025 Results with 14.3% Revenue Growth and Improved Margins

Jul 17, 2025
BTCY Biotricity, Inc.

Biotricity Pre-Announces Positive Adjusted EBITDA for Fiscal Year 2025

Jul 15, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Acquires Healthcare System-Owned Provider and Secures Preferred Provider Agreement with Ballad Health

Jul 07, 2025
QIPT Quipt Home Medical Corp.

Forager Capital Management Requests Quipt Home Medical Retract Statement and Terminate Standstill Agreement

Jun 04, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal from Forager Capital Management

May 21, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Reports Fiscal Second Quarter 2025 Results with Revenue Decline, Maintains Strong Adjusted EBITDA Margin

May 12, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Schedules Fiscal Second Quarter 2025 Financial Results Release

Apr 30, 2025
QIPT Quipt Home Medical Corp.

Multiple Insiders Acquire Shares in Quipt Home Medical Corp.

Apr 15, 2025
BTCY Biotricity, Inc.

Biotricity Recognized by Financial Times as One of the Americas' Fastest-Growing Companies 2025

Apr 08, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Unveils 2025 Strategic Priorities and Announces Annual General Meeting Results

Mar 24, 2025
BTCY Biotricity, Inc.

Biotricity Expands Intellectual Property Portfolio with 14 New Patents

Mar 12, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Reaches Cooperation Agreement with Kanen Wealth Management

Mar 04, 2025
BTCY Biotricity, Inc.

Biotricity Reports Record Margins, Revenues, and Cashflows with 21.7% Sales Growth for Q3 Fiscal Year 2025

Feb 20, 2025
BTCY Biotricity, Inc.

Biotricity Pre-Announces Cash Flow Breakeven and 11% Revenue Increase for Q3 Fiscal Year 2025

Feb 17, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Reports Fiscal First Quarter 2025 Results Amidst Operational Enhancements

Feb 10, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical Responds to Proxy Solicitation Notice from Kanen Wealth Management

Jan 31, 2025
QIPT Quipt Home Medical Corp.

Quipt Home Medical to Announce Fiscal First Quarter 2025 Financial Results

Jan 30, 2025
BTCY Biotricity, Inc.

Biotricity Partners with B-Secur to Launch Device-Neutral Cardiac Monitoring Platform

Jan 15, 2025
BTCY Biotricity, Inc.

Biotricity Secures Financing and Places Largest Inventory Order to Support Future Growth

Dec 27, 2024
QIPT Quipt Home Medical Corp.

Quipt Home Medical Reports Record Fiscal Year 2024 Revenue and Strong Adjusted EBITDA Margin

Dec 16, 2024
QIPT Quipt Home Medical Corp.

Quipt Home Medical Schedules Fiscal Fourth Quarter and Full Year 2024 Financial Results Release

Dec 04, 2024
BTCY Biotricity, Inc.

Biotricity Achieves Positive Free Cash Flow for Q2 Fiscal Year 2025

Dec 03, 2024
BTCY Biotricity, Inc.

Biotricity Reports Improved Margins, Sales Growth, and Positive Adjusted EBITDA for Q2 Fiscal Year 2025

Nov 15, 2024
BTCY Biotricity, Inc.

Biotricity Pre-Announces Shift to Positive Adjusted EBITDA for Q2 Fiscal Year 2025

Nov 13, 2024
BTCY Biotricity, Inc.

Biotricity Delisted from Nasdaq Stock Market

Aug 05, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks